Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) traded down 1.2% during mid-day trading on Wednesday . The stock traded as low as $1.66 and last traded at $1.69. 10,394,974 shares traded hands during trading, a decline of 59% from the average session volume of 25,050,621 shares. The stock had previously closed at $1.71.
Analyst Upgrades and Downgrades
Separately, Roth Mkm cut their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a research report on Friday, October 11th.
Read Our Latest Research Report on TLRY
Tilray Stock Down 1.8 %
The stock's fifty day moving average price is $1.72 and its 200-day moving average price is $1.80. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of -6.22 and a beta of 2.13. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.04). The business had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray's quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.10) earnings per share. On average, sell-side analysts predict that Tilray Inc will post -0.14 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray
A number of institutional investors have recently added to or reduced their stakes in the company. Prospect Financial Services LLC acquired a new stake in Tilray in the 2nd quarter valued at about $26,000. Signature Estate & Investment Advisors LLC acquired a new position in shares of Tilray during the 2nd quarter worth approximately $29,000. Jeppson Wealth Management LLC bought a new stake in Tilray in the 2nd quarter valued at $33,000. Vanguard Capital Wealth Advisors acquired a new stake in Tilray during the 2nd quarter valued at $34,000. Finally, HBK Sorce Advisory LLC acquired a new stake in Tilray during the 1st quarter valued at $37,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
